These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 21672551)
1. Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings. Luykx JJ; Laban KG; van den Heuvel MP; Boks MP; Mandl RC; Kahn RS; Bakker SC Neurosci Biobehav Rev; 2012 Jan; 36(1):198-205. PubMed ID: 21672551 [TBL] [Abstract][Full Text] [Related]
2. Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis. Godfrey KEM; Gardner AC; Kwon S; Chea W; Muthukumaraswamy SD J Psychiatr Res; 2018 Oct; 105():33-44. PubMed ID: 30144668 [TBL] [Abstract][Full Text] [Related]
3. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Hasler G; van der Veen JW; Tumonis T; Meyers N; Shen J; Drevets WC Arch Gen Psychiatry; 2007 Feb; 64(2):193-200. PubMed ID: 17283286 [TBL] [Abstract][Full Text] [Related]
4. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Yildiz-Yesiloglu A; Ankerst DP Psychiatry Res; 2006 Jun; 147(1):1-25. PubMed ID: 16806850 [TBL] [Abstract][Full Text] [Related]
5. Occipital gamma-aminobutyric acid and glutamate-glutamine alterations in major depressive disorder: An mrs study and meta-analysis. Truong V; Cheng PZ; Lee HC; Lane TJ; Hsu TY; Duncan NW Psychiatry Res Neuroimaging; 2021 Feb; 308():111238. PubMed ID: 33385764 [TBL] [Abstract][Full Text] [Related]
6. Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies. Moriguchi S; Takamiya A; Noda Y; Horita N; Wada M; Tsugawa S; Plitman E; Sano Y; Tarumi R; ElSalhy M; Katayama N; Ogyu K; Miyazaki T; Kishimoto T; Graff-Guerrero A; Meyer JH; Blumberger DM; Daskalakis ZJ; Mimura M; Nakajima S Mol Psychiatry; 2019 Jul; 24(7):952-964. PubMed ID: 30315224 [TBL] [Abstract][Full Text] [Related]
7. Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Rosenberg DR; Macmaster FP; Mirza Y; Smith JM; Easter PC; Banerjee SP; Bhandari R; Boyd C; Lynch M; Rose M; Ivey J; Villafuerte RA; Moore GJ; Renshaw P Biol Psychiatry; 2005 Nov; 58(9):700-4. PubMed ID: 16084860 [TBL] [Abstract][Full Text] [Related]
8. Dissociation of glutamate and cortical thickness is restricted to regions subserving trait but not state markers in major depressive disorder. Li M; Metzger CD; Li W; Safron A; van Tol MJ; Lord A; Krause AL; Borchardt V; Dou W; Genz A; Heinze HJ; He H; Walter M J Affect Disord; 2014 Dec; 169():91-100. PubMed ID: 25173431 [TBL] [Abstract][Full Text] [Related]
9. Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder. Kantrowitz JT; Dong Z; Milak MS; Rashid R; Kegeles LS; Javitt DC; Lieberman JA; John Mann J Transl Psychiatry; 2021 Aug; 11(1):419. PubMed ID: 34354048 [TBL] [Abstract][Full Text] [Related]
10. Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. Mirza Y; Tang J; Russell A; Banerjee SP; Bhandari R; Ivey J; Rose M; Moore GJ; Rosenberg DR J Am Acad Child Adolesc Psychiatry; 2004 Mar; 43(3):341-8. PubMed ID: 15076268 [TBL] [Abstract][Full Text] [Related]
12. Early life stress and glutamate neurotransmission in major depressive disorder. Averill LA; Abdallah CG; Fenton LR; Fasula MK; Jiang L; Rothman DL; Mason GF; Sanacora G Eur Neuropsychopharmacol; 2020 Jun; 35():71-80. PubMed ID: 32418842 [TBL] [Abstract][Full Text] [Related]
13. Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo. Das P; Tanious M; Fritz K; Dodd S; Dean OM; Berk M; Malhi GS Aust N Z J Psychiatry; 2013 Apr; 47(4):347-54. PubMed ID: 23341476 [TBL] [Abstract][Full Text] [Related]
14. Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex. Moore CM; Biederman J; Wozniak J; Mick E; Aleardi M; Wardrop M; Dougherty M; Harpold T; Hammerness P; Randall E; Lyoo IK; Renshaw PF J Affect Disord; 2007 Apr; 99(1-3):19-25. PubMed ID: 17005256 [TBL] [Abstract][Full Text] [Related]
15. Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder. Price RB; Shungu DC; Mao X; Nestadt P; Kelly C; Collins KA; Murrough JW; Charney DS; Mathew SJ Biol Psychiatry; 2009 May; 65(9):792-800. PubMed ID: 19058788 [TBL] [Abstract][Full Text] [Related]
16. Brain glutamate in medication-free depressed patients: a proton MRS study at 7 Tesla. Godlewska BR; Masaki C; Sharpley AL; Cowen PJ; Emir UE Psychol Med; 2018 Jul; 48(10):1731-1737. PubMed ID: 29224573 [TBL] [Abstract][Full Text] [Related]
17. Excitatory and inhibitory responses in the brain to experimental pain: A systematic review of MR spectroscopy studies. Archibald J; MacMillan EL; Enzler A; Jutzeler CR; Schweinhardt P; Kramer JLK Neuroimage; 2020 Jul; 215():116794. PubMed ID: 32278899 [TBL] [Abstract][Full Text] [Related]
18. A spectroscopic approach toward depression diagnosis: local metabolism meets functional connectivity. Demenescu LR; Colic L; Li M; Safron A; Biswal B; Metzger CD; Li S; Walter M Eur Arch Psychiatry Clin Neurosci; 2017 Mar; 267(2):95-105. PubMed ID: 27561792 [TBL] [Abstract][Full Text] [Related]
19. Could glutamate spectroscopy differentiate bipolar depression from unipolar? Taylor MJ J Affect Disord; 2014; 167():80-4. PubMed ID: 25082118 [TBL] [Abstract][Full Text] [Related]
20. Does the change in glutamate to GABA ratio correlate with change in depression severity? A randomized, double-blind clinical trial. Narayan GA; Hill KR; Wengler K; He X; Wang J; Yang J; Parsey RV; DeLorenzo C Mol Psychiatry; 2022 Sep; 27(9):3833-3841. PubMed ID: 35982258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]